Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01947673 · ClinicalTrials.gov registry record · NA

Mechanisms of Intradialytic Hypertension

A NA study of Hypertension and Renal Failure Chronic Requiring Hemodialysis, sponsored by Emory University.

Completed
Registry status
NA
Development phase
49
Enrollment target
1
Study location

NCT01947673 is a NA study of Hypertension and Renal Failure Chronic Requiring Hemodialysis that has completed, run by Emory University. The registered enrollment target is 49 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01947673, a NA study of Hypertension and Renal Failure Chronic Requiring Hemodialysis, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
49 participants
Enrollment target
1
Study location

Study Summary

Patients with end-stage renal disease (ESRD) are at significantly higher risk for death due to cardiovascular disease. Those with paradoxical increases in blood pressure (BP) during hemodialysis (HD), defined as intradialytic hypertension (IDH), are at even greater risk of cardiovascular mortality. This study seeks to determine the mechanisms that underlie IDH, and whether mindfulness meditation might improve BP during dialysis in these patients. The investigators will first determine if increased adrenaline levels during volume removal contributes to IDH. The investigators will then determine lack of suppression of adrenaline levels in the setting of a high BP also contributes to IDH. This will be done by manipulating blood pressure by using small amounts of vasoactive drugs, and determining if an appropriate response in adrenaline levels occurs. Lastly, the investigators will determine if an intradialytic mindfulness meditation program improves BP and adrenaline levels in ESRD patients with IDH.

Interventions

  • OTHER Health Education
  • OTHER Mindfulness Meditation

Study Locations (1)

Georgia

  • Emory Dialysis Clinics - Atlanta

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2013-09
Est. Completion 2017-11
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT01947673

The ClinicalTrials.gov registry entry for NCT01947673 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Health Education is the first listed.

NCT01947673 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT01947673 about?

NCT01947673 is a clinical study titled "Mechanisms of Intradialytic Hypertension". Patients with end-stage renal disease (ESRD) are at significantly higher risk for death due to cardiovascular disease. Those with paradoxical increases in blood pressure (BP) during hemodialysis (HD), defined as intradialytic hypertension (IDH), are at even greater risk of cardiovascular mortality. ...

What is the current status of trial NCT01947673?

This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2013-09. Estimated completion is 2017-11.

What conditions does trial NCT01947673 study?

This clinical trial studies the following conditions: Hypertension, Renal Failure Chronic Requiring Hemodialysis, Haemodialysis-induced Symptom.

What interventions are being tested in trial NCT01947673?

The interventions under investigation include: Health Education (OTHER), Mindfulness Meditation (OTHER).

Who is sponsoring clinical trial NCT01947673?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01947673 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.